Beckman Coulter Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Beckman Coulter Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7239
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Beckman Coulter Inc (Beckman), is a subsidiary of Danaher Corp, is a manufacturer of biomedical testing instrument systems. It develops, manufactures and markets biomedical laboratory instruments, software and other things that simplify and automate complex biomedical tests. The company offers its instruments, comprehensive diagnostic tests and business management services to hospitals, laboratories and other critical care settings worldwide. It provides scientific solutions for laboratory customers such as universities, biotechnology and pharmaceutical companies, government, hospitals, and commercial laboratories. It operates across the US, Canada, Europe and Asia with clinical and research systems operating in laboratories around the world. Beckman is headquartered in California, the US.

Beckman Coulter Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Beckman Coulter Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Beckman Coulter Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Beckman Coulter Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Beckman Coulter Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Beckman Coulter Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Beckman Coulter Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Beckman Coulter Acquires Clinical Microbiology Business from Siemens Healthcare Diagnostics 10
Partnerships 11
Grifols and Beckman Coulter Enter into Distribution Agreement 11
DiaSorin Enters into Agreement with Beckman Coulter 12
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 13
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 14
CellaVision Expands Distribution Agreement With Beckman Coulter 15
Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 16
Asset Transactions 17
GENEWIZ to Acquire Genomic Services Business of Beckman Coulter 17
Acquisition 18
Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 18
Beckman Coulter Inc – Key Competitors 19
Beckman Coulter Inc – Key Employees 20
Beckman Coulter Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Jun 21, 2018: UCI, Beckman Coulter Diagnostics announce strategic collaboration 25
Product News 26
Jun 19, 2018: Pivotal Study Reveals Effectiveness of Blood Tests in Screening for Sleep Apnea in Adult Males 26
Jan 04, 2018: Beckman Coulter Diagnostics Adds 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) Assays to Comprehensive Chemistry Test Menu 27
Jul 31, 2017: Beckman Coulter Highlights the First US IVD Test Delivering Flow Cytometric Leukemia & Lymphoma Analysis in the Routine Clinical Lab 28
Jun 05, 2017: Beckman Coulter Expands Role of AQUIOS CL Flow Cytometer in Routine Labs 30
Apr 20, 2017: Beckman Coulter Diagnostics Receives CE Mark and Expands Chemistry Menu to include Procalcitonin (PCT)Beckman Coulter Sample 31
Other Significant Developments 32
Jul 19, 2018: Beckman Coulter announces launch of DxONE PROService in Europe 32
Nov 27, 2017: Quidel Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay Assets 33
Jul 27, 2017: Beckman Coulter Diagnostics Introduces DxONE Clinical Information Management Tools 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Beckman Coulter Inc, Medical Equipment, Key Facts 2
Beckman Coulter Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Beckman Coulter Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Beckman Coulter Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Beckman Coulter Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Beckman Coulter Inc, Deals By Market, 2012 to YTD 2018 8
Beckman Coulter Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Beckman Coulter Acquires Clinical Microbiology Business from Siemens Healthcare Diagnostics 10
Grifols and Beckman Coulter Enter into Distribution Agreement 11
DiaSorin Enters into Agreement with Beckman Coulter 12
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 13
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 14
CellaVision Expands Distribution Agreement With Beckman Coulter 15
Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 16
GENEWIZ to Acquire Genomic Services Business of Beckman Coulter 17
Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 18
Beckman Coulter Inc, Key Competitors 19
Beckman Coulter Inc, Key Employees 20
Beckman Coulter Inc, Other Locations 22
Beckman Coulter Inc, Subsidiaries 22
Beckman Coulter Inc, Joint Venture 24

List of Figures
Beckman Coulter Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Beckman Coulter Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Beckman Coulter Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Beckman Coulter Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Beckman Coulter Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Beckman Coulter Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Beckman Coulter Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Beckman Coulter Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Beckman Coulter Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orbis S.A.:企業の戦略・SWOT・財務情報
    Orbis S.A. - Strategy, SWOT and Corporate Finance Report Summary Orbis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • DIAsource ImmunoAssays SA:企業の製品パイプライン分析2018
    Summary DIAsource ImmunoAssays SA (DIAsource), formerly BioSource Europe SA, a subsidiary of BioVendor - Laboratorni Medicina as, is a diagnostics company that develops, manufactures and markets clinical diagnostic products. The company’s products comprise immunoassays, antibodies, instruments and R …
  • Suncorp Group Ltd:企業の戦略・SWOT・財務分析
    Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • HomeWorks Tri-County Electric Cooperative Inc:発電所・企業SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • Pure Technologies Ltd:企業の戦略的SWOT分析
    Pure Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Arion Bank hf.:企業の戦略・SWOT・財務情報
    Arion Bank hf. - Strategy, SWOT and Corporate Finance Report Summary Arion Bank hf. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Capcom Co Ltd (9697):企業の財務・戦略的SWOT分析
    Capcom Co Ltd (9697) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務情報
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Emerald Health Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Sciences Inc (EHS) focuses to advance the development of cannabis in pharmaceutical, botanical and bioceutical applications. The company is developing EHP-101 based on cannabidiol for the treatment of multiple sclerosis (MS) and scleroderma; and EHP-102, derived from cannabige …
  • DecImmune Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DecImmune Therapeutics Inc (DecImmune) is a pharmaceutical research company. The company develops a humanised antibody, which is used in preventing tissue damage and block inflammation caused from vascular injuries. It conducts research and development on N2, an innate IgM-mediated auto-immu …
  • Torrent Pharmaceuticals Ltd (TORNTPHARM):企業の財務・戦略的SWOT分析
    Torrent Pharmaceuticals Ltd (TORNTPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Industrias Penoles SAB de CV:企業の戦略・SWOT・財務情報
    Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lytron Inc.:企業の戦略・SWOT・財務情報
    Lytron Inc. - Strategy, SWOT and Corporate Finance Report Summary Lytron Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kobayashi Pharmaceutical Co Ltd (4967)-医療機器分野:企業M&A・提携分析
    Summary Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body w …
  • Biotron Ltd (BIT):企業の財務・戦略的SWOT分析
    Biotron Ltd (BIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • University of California Irvine-製薬・医療分野:企業M&A・提携分析
    Summary University of California Irvine (UCI), a subsidiary of University of California is an educational university that provides undergraduate and graduate degree courses and research services. The university provides educational courses in various fields such as business, education, engineering, …
  • bioMerieux SA (BIM):企業の財務・戦略的SWOT分析
    bioMerieux SA (BIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Central Securities Corp (CET):企業の財務・戦略的SWOT分析
    Summary Central Securities Corp (Central Securities) is a financial service provider that provides investment services. The company offers investment management services and stock investment related services. It invests on convertible preferred stocks, bonds, preferred stocks, convertible bonds, war …
  • H&R Block, Inc.:戦略・SWOT・企業財務分析
    H&R Block, Inc. - Strategy, SWOT and Corporate Finance Report Summary H&R Block, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • EyeGate Pharmaceuticals Inc (EYEG):医療機器:M&Aディール及び事業提携情報
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆